‘Scromiting’: The Alarming Cannabis Side Effect Sending Patients to Emergency Rooms
The topic of ‘Scromiting’: Alarming Cannabis Side raises many questions. Medical professionals are raising concerns over a disturbing trend linked to cannabis consumption that has been flooding emergency departments across the country. The condition, which has earned the grim nickname “scromiting,” combines severe vomiting with uncontrollable screaming, and its prevalence has grown sharply over the last decade.
While the name might sound like something from a comedy sketch, the medical reality is far from amusing. Patients arriving at hospitals describe an agonizing cycle of relentless nausea, violent vomiting, and crippling abdominal pain that can leave them incapacitated for days at a time. Many of these individuals find themselves returning to the emergency room multiple times within a single year, seeking relief from the recurring episodes.
The underlying cause behind this surge in cases is a condition formally known as Cannabis Hyperemesis Syndrome, or CHS. This syndrome represents a paradoxical reaction to cannabis, where instead of the calming and anti-nausea effects often associated with the drug, users experience the exact opposite. The result is a debilitating state that has become a growing burden on healthcare systems.
Understanding the Painful Reality of Cannabis Hyperemesis Syndrome
For those unfamiliar with the condition, the symptoms of CHS are brutal and unrelenting. An episode typically begins within a 24-hour window following cannabis use and can persist for several days without respite. The physical toll is immense, as the body is subjected to repeated, forceful vomiting that leaves patients exhausted, dehydrated, and in severe distress.
The term “scromiting” was coined by emergency room staff who witness the unique and harrowing combination of symptoms firsthand. It describes the phenomenon where patients, overwhelmed by the sheer intensity of the pain and nausea, scream out involuntarily while in the throes of vomiting. This distinct presentation has become a recognizable pattern for medical teams working in acute care settings.
Dr. Beatriz Carlini, a research associate professor at the University of Washington School of Medicine, highlights the systemic impact of this syndrome. She notes that individuals suffering from CHS often make multiple visits to the emergency department before the condition is correctly identified. Each visit carries a significant financial burden, with costs accumulating to thousands of dollars per patient as they seek answers and relief from their symptoms.
Why Standard Treatments Often Fall Short
One of the most challenging aspects of managing CHS is the difficulty in treating it effectively. Dr. Chris Buresh, an emergency medicine specialist, points out that there are currently no therapies approved by the Food and Drug Administration specifically for this syndrome. This lack of targeted treatment options leaves physicians in a difficult position when trying to alleviate a patient’s suffering.
Standard anti-nausea medications, which are typically effective for other causes of vomiting, often prove useless against the intense symptoms of CHS. This forces doctors to think creatively and explore unconventional remedies in their quest to provide relief. Some of these alternative approaches include having patients take hot baths or showers, which has been reported to ease symptoms for some individuals.
Other treatments that have been utilized in emergency settings include the topical application of capsaicin cream to the stomach area. Capsaicin, the active component in chili peppers, is used in this context to potentially interrupt pain signals. In more severe cases, physicians have turned to Haldol, a medication that is more commonly associated with treating psychotic episodes, as a last resort to break the cycle of vomiting.
For Dr. Buresh, the response to hot water is a telling diagnostic clue. When a patient mentions that their symptoms improve after taking a hot shower, it serves as a strong indicator that they are dealing with CHS. He describes how patients often report using up all the hot water in their house in a desperate attempt to find some measure of comfort from the relentless discomfort.
Identifying Those at Risk for Scromiting
The question of who is most vulnerable to developing CHS remains a subject of ongoing research. What is clear is that the syndrome does not discriminate based on frequency or quantity of use in the same way other conditions might. Even individuals who consider themselves moderate or occasional users can find themselves suddenly susceptible to these severe episodes.
Dr. Buresh explains that there appears to be a threshold that determines a person’s vulnerability to the condition. This threshold is highly individualized, meaning that what triggers symptoms in one person may have no effect on another. He emphasizes that even minimal amounts of cannabis can be enough to induce vomiting in those who have crossed this personal line of susceptibility.
Another critical aspect of CHS is its tendency to recur. The syndrome strikes intermittently, which can create a false sense of security for users. Dr. Carlini warns that some individuals who experience an episode may dismiss it as an isolated incident, failing to connect it to their cannabis use. This misinterpretation often leads them to continue their habits, only to suffer another severe bout of illness in the future.
The only definitive way to eliminate the condition is to cease cannabis consumption entirely. However, achieving this can be a significant hurdle for many users, as the addictive nature of the substance makes abstinence a considerable challenge. Long-term recovery is often contingent on a complete cessation of use, a step that requires substantial willpower and support.
Scientific Theories Behind the Syndrome
Researchers are still working to unravel the precise mechanisms that cause CHS to develop in some users but not others. The leading scientific theory centers on the endocannabinoid system, a complex cell-signaling system in the body that plays a role in regulating a wide range of functions, including appetite, pain sensation, and nausea.
The hypothesis suggests that chronic, heavy cannabis use overstimulates this system. This overstimulation is believed to disrupt the body’s natural ability to regulate nausea and vomiting, essentially throwing the system out of balance. Instead of functioning normally, the body’s digestive and neurological responses become dysregulated, leading to the extreme symptoms associated with CHS.
Data collected from a study conducted at George Washington University adds weight to the understanding of risk factors. The research, which surveyed more than 1,000 patients who had been diagnosed with CHS, found a strong correlation between early onset of cannabis use, prolonged use over time, and the likelihood of requiring emergency care for scromiting episodes.
A Growing Concern Among Young Users
Perhaps one of the most troubling trends in the data is the sharp increase in cases among adolescents. Statistics from the United States reveal that the number of adolescent cases has jumped more than tenfold between 2016 and 2023. This dramatic rise points to a growing public health issue that is affecting younger demographics at an alarming rate.
Interestingly, the geographic distribution of these cases presents a complex picture. Overall, CHS cases are more frequently reported in states where recreational cannabis is legal. This could be attributed to higher rates of use and greater accessibility in those areas. However, the data takes an unexpected turn when focusing specifically on younger patients.
For adolescents, the fastest increases in CHS cases are occurring in states where recreational cannabis remains illegal. This counterintuitive finding suggests that factors beyond mere legality are at play, possibly including variations in the potency of black-market products or differing patterns of consumption among teens in those regions.
‘Scromiting’: Alarming Cannabis Side: Official Recognition and the Path Forward
In a significant development for the medical community, the World Health Organization formally recognized Cannabis Hyperemesis Syndrome on October 1, 2025. This recognition came with the assignment of an official diagnosis code, a move that has important implications for both patients and healthcare providers.
Having a distinct code allows for more accurate tracking of the condition’s prevalence and impact. Dr. Carlini explains that this new code will supply essential hard evidence regarding adverse events related to cannabis. This data is crucial, as physicians have been indicating that problems stemming from cannabis use are a growing concern that needs to be better understood and addressed.
With emergency room visits continuing to climb, experts are urging both teens and adults who use cannabis to be aware of the potential risks. The condition can be debilitating, and the path to recovery is not simple. Awareness and education are seen as key components in helping individuals recognize the signs early and understand the serious consequences that can arise from cannabis use.
